Purchase Order 75N90025P00191
- Not listed
- Laboratory Corporation of America (LabCorp) has been awarded a firm fixed price purchase order valued at $20,000 by the Department of Health and Human Services' National Institutes of Health Clinical Center. The order is for laboratory testing services to be performed by LabCorp at its facility located in Greenwood Village, Colorado. No set-aside designation was applied to this procurement. As the prime contractor, LabCorp will provide unspecified testing services to support the NIH Clinical...
- This is a firm-fixed-price purchase order awarded by the National Institutes of Health (NIH) Clinical Center to Laboratory Corporation of America (Labcorp), a large publicly traded clinical laboratory company. The contract has a ceiling value of $90,000.00 and an ultimate completion date of February 14, 2022. Labcorp is providing a range of laboratory testing and analysis services to support NIH's healthcare programs. This includes reference laboratory testing, genomic screening, specimen...
- This is a firm fixed-price purchase order contract awarded by the Department of Health and Human Services (HHS) to Laboratory Corporation of America (LabCorp) on March 10, 2016 with a ceiling value of $45,000.00. The contract was not set aside for any specific business type. Under this contract, LabCorp is providing laboratory testing services related to Congenital Adrenal Hyperplasia and other medical testing. LabCorp has also received subcontract awards from Leidos Biomedical Research Inc....
- This is a firm-fixed-price purchase order awarded by the National Heart Lung and Blood Institute (NHLBI), a civilian agency under the National Institutes of Health (NIH), to Labcorp Early Development Laboratories Inc., a for-profit subsidiary of Laboratory Corporation of America Holdings. The contract, valued at $113,830.32, is for the company to perform whole genome DNA methylation profiling and genotyping on 580 DNA samples. The work is to be conducted at the contractor's facility in...
- This contract is a $200,000.00 firm fixed price purchase order awarded by the Department of Health and Human Services' Indian Health Service to Laboratory Corporation of America (LabCorp), a large for-profit clinical laboratory testing provider. The contract is for the payment of outstanding invoices and does not have a set-aside designation. Based on LabCorp's history of supporting government health agencies, this award is likely part of a broader set of contracts where LabCorp provides a...
- This is a $14,500 firm fixed-price purchase order contract awarded by the National Cancer Institute (NCI) to Labcorp Genetics Inc., a for-profit manufacturer of goods specializing in genetic testing and laboratory services. The contract is for genetic testing services, with a performance period from July 1, 2025 to June 30, 2026. The contract does not have a set-aside designation. Labcorp Genetics Inc. has secured multiple federal contract awards from agencies like NCI and the Veterans...
- This is a federal contract award to Laboratory Corporation of America (Labcorp), a leading global life sciences company, by the National Human Genome Research Institute (NHGRI), a civilian agency under the Department of Health and Human Services. The contract, valued at $62,375.00, is a firm-fixed-price Delivery Order under Labcorp's General Services Administration (GSA) Federal Supply Schedule contract for Medical Laboratory Testing and Analysis Services (FSS-621-II). The contract is not set...
- This is a $207,010.40 firm fixed-price delivery order contract awarded by the National Institute of Environmental Health Sciences (NIEHS), a civilian agency, to the Laboratory Corporation of America (Labcorp) for NextGen Sequencing and Omics Services. The contract has an ultimate completion date of August 1, 2020. Labcorp, a subsidiary of Laboratory Corporation of America Holdings, is a leading global life sciences company that provides comprehensive clinical laboratory services to federal...
- This firm-fixed-price purchase order was awarded by the National Human Genome Research Institute (NHGRI), a civilian federal agency, to Laboratory Corporation of America (LabCorp) for the provision of noninvasive prenatal testing (NIPT) services. The contract, which does not have a set-aside designation, has a ceiling value of $24,950.00 and an ultimate completion date of September 30, 2024. LabCorp, a leading global life sciences company, is the prime contractor and will deliver a range of...
- This is a $165,000.00 firm-fixed-price purchase order contract awarded by the National Institute on Aging (NIA), a civilian agency, to Laboratory Corporation of America (Labcorp) for a longitudinal study of sex differences in autoantibodies and autoimmune diseases with aging. The contract has a period of performance through December 31, 2026 and is not set aside for small businesses. Labcorp is a large for-profit organization that specializes in providing comprehensive diagnostic testing and...
The NIH Clinical Center awarded a $12,000 firm fixed-price purchase order to Laboratory Corporation of America (LabCorp) on February 13, 2025, for laboratory testing and genotyping services related to congenital adrenal hyperplasia (CAH) research. The contract encompasses genetic analysis and measurement of multiple CAH-specific hormones, including 11-oxo-androgens, with services to be performed at LabCorp's Greenwood Village, Colorado facility. No set-aside designation was applied to this procurement, and the contract is scheduled for completion by September 30, 2025. LabCorp, a large for-profit clinical laboratory testing provider with significant experience in federal health research contracts, is well-positioned to deliver these specialized diagnostic services. The company's established track record with the NIH Clinical Center and Indian Health Service in hormone evaluation and genetic testing—particularly in CAH-related research—demonstrates their capability to support the clinical research and patient care initiatives underlying this procurement. The work will likely involve processing blood specimens and conducting genetic analysis in accordance with institutional review board-approved protocols.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00001 | Funding Only Action | $2.0k | 9/9/25 | |
| Not listed | Not listed | $10.0k | 2/14/25 |